CRP and infection: In this study, we tested the overall hypothesis that if the amyloid-expressing proteins on the pneumococcal surface are blocked by E-CRP-1/-2, then WT CRP should be able to protect mice against all stages of pneumococcal infection; for example, WT CRP should be able to protect mice against infection even when administered to mice 12 h post-inoculation.